26 May 2022
Intuitive Investments Group plc
Update on Sanondaf
Sanondaf awards new regional franchise and key appointments
Intuitive Investments Group plc, (AIM: IIG) ("IIG") announces the following update in respect of its largest single investment, Sanondaf.
Sanondaf awards new regional franchise
Sanondaf, a specialist disinfection and hygiene services business, has awarded a regional franchise in Kent, which covers the Discovery Science Park in Sandwich. The franchise will be headed by John Wamsley who runs a successful equipment supply and reconditioning business. He has an extensive knowledge of, and excellent relationships in, the life sciences sector.
This new regional franchise increases the number of regional franchises to 26, giving excellent and growing coverage throughout the United Kingdom. The award is in line with Sanondaf's targeted growth strategy in the life science sector. Sanondaf is a trusted partner of companies ranging from life science start-ups to multi-nationals. Customers include the NHS, research laboratories and pharmaceutical manufacturers.
Strengthening of the Sanondaf Team
Furthermore, Sanondaf announces three appointments.
Tom Hyland, Operations Director, has held senior positions in global life sciences companies including Johnson & Johnson Medical, Microsulis, Life Technologies and Alere Technologies. Tom started his career as a chemical engineer, has a chemistry degree and holds an MBA. Tom combines excellent technical engineering ability with exceptional managerial skills and will be responsible for operations and product development.
Collette McMorrow, Business Manager, has proven expertise in marketing, project management, business development and event management. Collette has held senior roles in leading companies such as Bayer and has a proven track record in digital system design, leadership, and performance management.
Helen McPike, Product Specialist, is a biosecurity specialist who has 20 years' experience in healthcare and has spent the last eight years working in the infection prevention and control sector. Helen has held senior sales roles and worked for the NHS, Byotrol and Fresnius and has first class honours science degree in Health Science.
For further information, please contact:
Intuitive Investments Group plc | |
Julian Baines, Non-Executive Chairman Robert Naylor, CEO | Via Walbrook PR |
| |
SP Angel Corporate Finance LLP - Nominated Adviser | +44 (0) 20 3470 0470 |
Jeff Keating / David Hignell / Kasia Brzozowska
| |
Turner Pope Investments (TPI) Ltd - Broker | +44 (0) 20 3657 0050 |
Andrew Thacker / James Pope | |
| |
Walbrook PR Limited - Media & Investor Relations | +44 (0)20 7933 8780 or intuitive@walbrookpr.com |
Paul McManus/ Sam Allen | +44 (0) 7980 541 893 / +44 (0) 7502 558 258 |
About Sanondaf
Sanondaf provides specialist disinfection and hygiene services, primarily through its core technology of spraying and fogging. Sanondaf's decontamination service is based around a hydrogen peroxide formula, which is administered as a dry vapour disinfection treatment which can be used on all electrical and electronic devices and all hard and soft furnishings safely, without causing damage or leaving any unsightly residue on the surfaces treated. Treatments are non-corrosive, contain no toxic ingredients and Sanondaf's application methods ensure they are not harmful to people, animals or the environment. It is safe for use in all settings, including operating theatres, critical care units, and is CASA (Civil Aviation Safety Authority) approved. Sanondaf's disinfection formula has proven efficacy against pathogens, including, viruses such as Covid-19 and Monkeypox, mould, bacteria and fungi.
About Intuitive Investments Group plc
The Company is an investment company seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the chairman of the Investment Committee, David Evans, to seek to generate capital growth over the long term for shareholders.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.